Skip to content

Efficacy of Capsaicin Nasal Spray in Non-allergic rhinitis : A pilot study

Efficacy of Capsaicin Nasal Spray in Non-allergic rhinitis : A pilot study

Status
Unknown
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241008002
Enrollment
10
Registered
2024-10-08
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intranasal capsaicin has been reported to be beneficial in non allergic rhinitis symptom control. capsaicin nasal spray, non allergic rhinitis

Interventions

0.01mM capsaicin nasal spray was used to apply 2puff once daily each nostril every day for 2 weeks.,0.05mM capsaicin nasal spray was used to apply 2puff once daily each nostril every day for 2 weeks.
Active Comparator Drug,Active Comparator Drug
0.01mM capsaicin nasal spray,0.05mM capsaicin nasal spray

Sponsors

Faculty of Medicine Siriraj Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient who was diagnosed non allergic rhinitis

Exclusion criteria

Exclusion criteria: 1.Use of systemic or inhaled corticosteroids in the previous month. 2.History of nasal surgery 3.Cormobid of nasal polyps or sinonasal tumor. 4.Comorbid of significant anatomical abnormalities affecting nasal function. 5.Comorbid of nasal or paranasal sinus infection 6. Patient who has drug-induced rhinitis, inability of the patient to stop taking medication affecting nasal function. 7.History of capsaicin allergy. 8.Pregnancy or lactation. 9.Smoking 10.Comorbid of asthma or atopic dermatitis

Design outcomes

Primary

MeasureTime frame
Efficacy of capsaicin nasal spray in non allergic rhinitis patients. within two weeks after end of the intervention compare visual analogue scale of nasal symptoms before and after intervention

Secondary

MeasureTime frame
Side effects of capsaicin nasal spray within two weeks after end of the intervention percentage of side effects

Countries

Thailand

Contacts

Public ContactTriphoom Suwanwech

Siriraj Hospital

triphoom.suw@mahidol.ac.th0819150986

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026